The capsule differs from competitor Given Imaging’s PillCam because it uses low-energy X-rays instead of light. This produces a different image and could eliminate the need for typical GI tract preparation because X-rays penetrate through soft material like food. The technology could be used to screen for colorectal cancer as well as other diseases of the GI tract.
Check-Cap plans to introduce the technology in Europe before the end of 2013 and is currently in talks with the FDA.
Related Articles on Gastroenterology:
Colorectal Cancer Screening Rates by the Numbers: 12 Recent Statistics
Study: Demand for Screening Colonoscopy Down During Recession
Global Endoscopy Market Expected to Grow 13.2% in Next Three Years
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
